2004
DOI: 10.1111/j.1600-0609.2004.00341.x
|View full text |Cite
|
Sign up to set email alerts
|

Improvement of idiopathic thrombocytopenic purpura by antithyroid therapy

Abstract: Here we report a case of idiopathic thrombocytopenic purpura accompanied by Graves' disease. Improvement in thyroid function with methimazole led to the spontaneous recovery of the platelet count from 8 x 10(9)/L to 84 x 10(9)/L. Furthermore, the second fall and recovery of the platelet count well coincided with the recurrence of hyperthyroidism after the discontinuation of methimazole and its normalization by resumption of the drug, respectively. These parallel fluctuations of platelet and thyrotropin because… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
19
1

Year Published

2008
2008
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(20 citation statements)
references
References 7 publications
0
19
1
Order By: Relevance
“…ITP may present itself earlier or at a significantly different time to the diagnosis of thyroid disorders. Timing between the diagnosis of ITP and thyroid disease can vary from months to years [18,19]. In our study, no thyroid dysfunction such as hypo or hyperthyroidism was detected in the patients whose thyroid autoantibodies were positive.…”
Section: Discussioncontrasting
confidence: 60%
“…ITP may present itself earlier or at a significantly different time to the diagnosis of thyroid disorders. Timing between the diagnosis of ITP and thyroid disease can vary from months to years [18,19]. In our study, no thyroid dysfunction such as hypo or hyperthyroidism was detected in the patients whose thyroid autoantibodies were positive.…”
Section: Discussioncontrasting
confidence: 60%
“…Interestingly, the control of hyperthyroidism and the restoration of a euthyroid state by antithyroid drug therapy resulted in the complete and lasting remission of the coagulation disorder [23]. This beneficial effect on platelet count of antithyroid agents, probably due to their immunomodulatory activity [39], has also been observed by other authors [32]. In addition, Bowles et al [38] documented the case of a 52-year-old woman with chronic severe thrombocytopenia refractory to steroids, immunosuppression, immunoglobulin, and splenectomy successfully treated with thyroxine.…”
Section: Introductionmentioning
confidence: 56%
“…Graves’ disease is an autoimmune disorder characterized by hyperthyroidism, ophthalmopathy, and dermopathy, which can be complicated by various autoimmune blood disorders, including hemolytic anemia [4], idiopathic thrombocytopenic purpura [5], and iron deficiency anemia [6]. …”
Section: Introductionmentioning
confidence: 99%